Clinical OMICS

MAR-APR 2018

Healthcare magazine for research scientists, labs, pathologists, hospitals, cancer centers, physicians and biopharma companies providing news articles, expert interviews and videos about molecular diagnostics in precision medicine

Issue link:

Contents of this Issue


Page 3 of 51

See how the DNAnexus Clinical Trial Soluধon can improve trial results, while reducing the ধme and cost of clinical development. Learn more at The DNAnexus cloud-based Clinical Trial Soluধon (CTS) enables the use of genomic and other -omic informaধon in combinaধon with trials data, so you can opধmize and de-risk later phases through biomarker-driven parধcipant selecধon and intervenধon guidance. The DNAnexus PlaĤorm can provide secure and compliant services for all of your clinical needs, from early development through clinical trials, as well as for clinical diagnosধcs. Opধmize and de-risk your clinical trials with biomarker-driven paধent selecধon

Articles in this issue

Links on this page

Archives of this issue

view archives of Clinical OMICS - MAR-APR 2018